Glutamatergic Dysfunction

Glutamatergic Dysfunction is a pathophysiological construct in neuropharmacology denoting an aberration in glutamatergic neurotransmission characterized by disrupted synaptic signaling, receptor desensitization, or excitotoxic mechanisms that deviate from normative glutamatergic function.

1.6K

Publications

114.8K

Citations

8.8K

Authors

1.9K

Institutions

Publications per year

2017–2026

437

Authors

8.8K

  1. KT
    Kohichi Tanaka

    Tokyo Medical and Dental University, Japan

    16 publications · 3K citations

    15

    h-index

  2. OH
    Oliver Howes

    King's College London, United Kingdom

    14 publications · 1.3K citations

    13

    h-index

  3. VH
    Vahram Haroutunian

    Icahn School of Medicine at Mount Sinai, United States

    11 publications · 1.2K citations

    11

    h-index

  4. DO
    Diogo O. Souza

    Universidade Federal do Rio Grande do Sul, Brazil

    11 publications · 366 citations

    11

    h-index

  5. PJ
    Paul J. Harrison

    University of Oxford, United Kingdom

    10 publications · 862 citations

    10

    h-index

1–5 of 8.8K

Venues

  1. Journal of Neuroscience

    36 publications · 3.5K citations

    32

    h-index

  2. Brain Research

    54 publications · 3.3K citations

    28

    h-index

  3. PubMed

    Repository · 43 publications · 2.7K citations

    27

    h-index

  4. Neuroscience

    31 publications · 2.1K citations

    26

    h-index

  5. Journal of Neurochemistry

    JNC · 23 publications · 2.1K citations

    22

    h-index

1–5